Randomised, double-blind, placebo-controlled, parallel group trial to confirm the efficacy, safety and tolerability of Ginkgo biloba Special Extract EGb 761 in patients suffering from Mild Mental Impairment (MMI).
Phase of Trial: Phase III
Latest Information Update: 26 May 2011
At a glance
- Drugs EGb 761 (Primary)
- Indications Mental disorders
- Focus Adverse reactions; Therapeutic Use
- 26 May 2011 New trial record